FDA Repeals Emergency Authorization Use Of Chloroquine & Hydroxychloroquine
The FDA has revoked the EUA granted to the antimalarial drugs chloroquine phosphate and the less toxic metabolite hydroxychloroquine sulfate for treatments against COVID-19, this repeal cites a lack of consistent replication of earlier results and a randomized clinical trial that showed no benefit. The drugs have become a popular topic of discussion after being …